Hereditary Systemic Amyloidosis Panel

Nephrology

Hereditary Systemic Amyloidosis Panel

Overview

Test Name
Hereditary Systemic Amyloidosis Panel
Test Code
NEE1008
Test Category
Gene Panels
Test Subcategory
Nephrology
Disease(s) Targeted
Hereditary systemic amyloidosis
Who Is The Test For?
Patients with a family history, clinical suspicion, or diagnosis of hereditary systemic amyloidosis.
Test Approach

Whole exome sequencing (WES) with in silico gene panel analysis.

No. of Genes
7
Panel Content
APOA1, APOA2, APOC2, FGA, GSN, LYZ, TTR
Deliverables
Turnaround Time

~3-6 weeks*

Specimen Requirements

For detailed information about the sample requirements, please consult our clinical sample requirements page.

*Turnaround times are estimated from receipt of satisfactory specimen and test request form at the laboratory to release of clinical report. The turnaround time may vary depending on the nature of the specimen and the complexity of the investigation required. The above table is only a guideline and the complexity of a case and the requirement for further investigations may change this.

About Hereditary systemic amyloidosis

Hereditary systemic amyloidosis is an inherited condition where mutated proteins, often transthyretin (TTR), misfold into harmful fibrils that deposit in organs, causing dysfunction and failure. It is an autosomal dominant disease, meaning a single copy of the altered gene from either parent can cause the condition. The most common type is hereditary transthyretin amyloidosis (ATTR), but other hereditary forms involve variants in genes for apolipoproteins A-I (APOA1), A-II (APOA2), C-II (APOC2), fibrinogen (FGA), gelsolin (GSN) and lysozyme (LYZ).

Gene Panel Workflow

Order a test using our clinical portal

Preview Documents

©2023 Genseq All Rights Reserved.

Terms & Conditions
Privacy Policy
Cookie Policy
Cookie Preferences